Literature DB >> 15725931

Ureteroscopic management of upper urinary tract transitional cell carcinoma.

G Blake Johnson1, Michael Grasso.   

Abstract

PURPOSE OF REVIEW: Traditionally, nephroureterectomy has been the treatment of choice for transitional cell carcinoma of the upper urinary tract. In an effort to preserve renal function, conservative therapy has evolved from complex open surgery to minimally invasive ureteroscopic therapy. Considering the relatively recent emergence of ureteroscopic therapy, a review of technical considerations and treatment outcome is timely. RECENT
FINDINGS: There is emerging evidence that ureteroscopic treatment of low grade upper tract lesions provides an acceptable oncologic result while preserving functioning renal parenchyma. In patients with low grade upper tract urothelial lesions, progression is rarely reported. Ureteroscopy has for over a decade been the premier diagnostic tool, with the actively deflectable flexible instrument being employed to map the entire intrarenal collecting system. Improvements in instrumentation and refinement in technique have broadened the application of the ureteroscope in treating upper urinary tract urothelial tumors.
SUMMARY: For low grade lesions, which make up more than 50% of all presentations, ureteroscopic management has proven efficacious. As with similar grade lesions in the bladder, these patients require careful, consistent, and often lifelong follow up as many will develop recurrent lesions throughout the urothelium. Here too, ureteroscopy has a central role in surveillance.

Entities:  

Mesh:

Year:  2005        PMID: 15725931     DOI: 10.1097/01.mou.0000160622.13366.a1

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  9 in total

1.  Thulium laser for the treatment of upper urinary tract carcinoma (UTUC)? Are we there, yet?

Authors:  Esteban Emiliani; Thomas R W Herrmann; Alberto Breda
Journal:  World J Urol       Date:  2015-02-22       Impact factor: 4.226

Review 2.  Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management.

Authors:  Julia V Fiuk; Brad F Schwartz
Journal:  World J Nephrol       Date:  2016-03-06

Review 3.  Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.

Authors:  Rao S Mandalapu; Mesut Remzi; Theo M de Reijke; Vitaly Margulis; J Palou; A Kapoor; Ofer Yossepowitch; Jonathan Coleman; Olivier Traxer; J Kyle Anderson; James Catto; Jean de la Rosette; Timothy O'Brien; Anthony Zlotta; Surena F Matin
Journal:  World J Urol       Date:  2016-05-27       Impact factor: 4.226

Review 4.  Risk-adapted strategy for the kidney-sparing management of upper tract tumours.

Authors:  Thomas Seisen; Pierre Colin; Morgan Rouprêt
Journal:  Nat Rev Urol       Date:  2015-02-24       Impact factor: 14.432

5.  Laser photoablation of renal pelvic tumours.

Authors:  Bryce Weber; Theresa J McCallum; John Tulip; Ronald B Moore
Journal:  Can Urol Assoc J       Date:  2008-08       Impact factor: 1.862

6.  Multidetector CT imaging features of invasive renal parenchyma urothelial carcinoma.

Authors:  Qingqiang Zhu; Wenrong Zhu; Jingtao Wu; Wenxin Chen
Journal:  Br J Radiol       Date:  2016-05-05       Impact factor: 3.039

7.  Ureteroscopic laser treatment of upper urinary tract urothelial cell carcinomas: can a tumour free status be achieved?

Authors:  Christos Kalaitzis; Athanasios Zisimopoulos; Stilianos Giannakopoulos; Stavros Touloupidis
Journal:  Adv Urol       Date:  2013-09-12

8.  Prognostic factors in laser treatment of upper urinary tract urothelial tumours.

Authors:  Gh Niţă; D Georgescu; R Mulţescu; M Draguţescu; B Mihai; B Geavlete; C Persu; P Geavlete
Journal:  J Med Life       Date:  2012-03-05

9.  Holmium:YAG laser ablation of upper urinary tract transitional cell carcinoma with new Olympus digital flexible ureteroscope.

Authors:  Pablo Garrido Abad; Almudena Coloma Del Peso; Manuel Fernández Arjona
Journal:  Urol Ann       Date:  2013-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.